4
MARKET OVERVIEW
Presents a concise view of industry direction, strategic priorities, and key indicators influencing market momentum.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET
5.5.1
AVERAGE SELLING PRICE TREND OF VACCINES, BY KEY PLAYER, 2023–2025
5.5.2
AVERAGE SELLING PRICE TREND OF VACCINES, BY DISEASE INDICATION, 2023–2025
5.5.3
AVERAGE SELLING PRICE TREND OF VACCINES, BY REGION, 2021–2023
5.6.1
IMPORT SCENARIO (HS CODE 300220)
5.6.2
EXPORT SCENARIO (HS CODE 300220)
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF ON RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
ADJACENT TECHNOLOGIES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
9.3
INACTIVATED & SUBUNIT VACCINES
10
RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET, BY TYPE, 2023-2030 (USD MILLION)
10.3
MULTIVALENT VACCINES
11
RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET, BY END USER, 2023-2030 (USD MILLION)
12
RESPIRATORY SYNCYTIAL VIRUS VACCINES MARKET, BY REGION, 2023-2030 (USD MILLION)
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.5
REST OF ASIA PACIFIC
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.4
REST OF LATIN AMERICA
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST
12.6.2.2
KINGDOM OF SAUDI ARABIA
12.6.2.3
REST OF GCC COUNTRIES
12.6.3
REST OF MIDDLE EAST
12.7.1
MACROECONOMIC OUTLOOK FOR AFRICA
13.2
KEY PLAYERS STRATEGY/RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2022-2024
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
TECHNOLOGY FOOTPRINT
13.5.5.5
ROUTE OF ADMINISTRATION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.7
COMPETITIVE SCENARIO
16.7.3
OTHER DEVELOPMENTS
16.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
16.9
COMPANY VALUATION AND FINANCIAL METRICS
14.1.5
CLOVER BIOPHARMACEUTICALS
15.1.1.1
KEY SOURCES OF SECONDARY DATA
15.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
15.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
15.2
MARKET SIZE ESTIMATION
15.2.1
RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINES MARKET SIZE ESTIMATION
15.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.2.1.2
MNM REPOSITORY ANALYSIS
15.2.1.3
SECONDARY ANALYSIS
15.2.1.4
PRIMARY RESEARCH
15.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
15.3
MARKET GROWTH RATE PROJECTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Respiratory Syncytial Virus (RSV) Vaccines Market